Moderna has produced the first Canadian-made doses of its mRNA vaccines in its new facility in Laval, Que., the company’s CEO says.
“We want to bring this mRNA technology to help as many people as we can,” Moderna CEO Stéphane Bancel said at a Sept. 19 press conference in Laval. “COVID is just the beginning. We have so many more exciting products coming in infectious disease, but also cancer, in rare genetic disease, and soon, I believe, in autoimmune disease.”
Moderna’s Spikevax product that makes up the mRNA vaccine is now being manufactured at the production facility in Laval, and the new single-use syringes will be pre-filled by Novocol Pharma at a “fill-finish” facility in Cambridge, Ont….